<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="hsr270502" xml:lang="en" article-type="article-commentary"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Health Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Health Sci Rep</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2398-8835</journal-id><journal-id journal-id-type="publisher-id">HSR2</journal-id><journal-title-group><journal-title>Health Science Reports</journal-title></journal-title-group><issn pub-type="epub">2398-8835</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39995799</article-id><article-id pub-id-type="pmc">PMC11847710</article-id>
<article-id pub-id-type="doi">10.1002/hsr2.70502</article-id><article-id pub-id-type="publisher-id">HSR270502</article-id><article-categories><subj-group subj-group-type="overline"><subject>Perspective</subject></subj-group><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Bridging the Gap: The Role of Continuous Positive Airway Pressure Therapy in Diabetic Retinopathy Associated With Obstructive Sleep Apnea&#x02013;A Perspective</article-title></title-group><contrib-group><contrib id="hsr270502-cr-0001" contrib-type="author"><name><surname>Ayoub</surname><given-names>Sadia</given-names></name><xref rid="hsr270502-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hsr270502-cr-0002" contrib-type="author"><name><surname>Tanweer</surname><given-names>Hira</given-names></name><xref rid="hsr270502-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hsr270502-cr-0003" contrib-type="author"><name><surname>Javaid</surname><given-names>Hafiza Aiman</given-names></name><xref rid="hsr270502-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="hsr270502-cr-0004" contrib-type="author"><name><surname>Khan</surname><given-names>Minahil Nasreen</given-names></name><xref rid="hsr270502-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="hsr270502-cr-0005" contrib-type="author"><name><surname>Ahmed</surname><given-names>Shahzaib</given-names></name><xref rid="hsr270502-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="hsr270502-cr-0006" contrib-type="author" corresp="yes"><name><surname>Eljack</surname><given-names>Mohammed Mahmmoud Fadelallah</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2370-9368</contrib-id><xref rid="hsr270502-aff-0006" ref-type="aff">
<sup>6</sup>
</xref><address><email>m.mahmmoud96@gmail.com</email></address></contrib></contrib-group><aff id="hsr270502-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Jinnah Sindh Medical University</institution>
<city>Karachi</city>
<country country="PK">Pakistan</country>
</aff><aff id="hsr270502-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>Isra University</institution>
<city>Hyderabad</city>
<country country="PK">Pakistan</country>
</aff><aff id="hsr270502-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Fazaia Ruth Pfau Medical College</institution>
<city>Karachi</city>
<country country="PK">Pakistan</country>
</aff><aff id="hsr270502-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Central Park Medical College</institution>
<city>Lahore</city>
<country country="PK">Pakistan</country>
</aff><aff id="hsr270502-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>Fatima Memorial Hospital College of Medicine and Dentistry</institution>
<city>Lahore</city>
<country country="PK">Pakistan</country>
</aff><aff id="hsr270502-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Community Department</named-content>
<institution>University of Bakht Alruda</institution>
<city>Ad Duwaym</city>
<country country="SD">Sudan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold> Mohammed Mahmmoud Fadelallah Eljack (<email>m.mahmmoud96@gmail.com</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>8</volume><issue seq="30">2</issue><issue-id pub-id-type="doi">10.1002/hsr2.v8.2</issue-id><elocation-id>e70502</elocation-id><history>
<date date-type="rev-recd"><day>29</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>15</day><month>11</month><year>2024</year></date>
<date date-type="accepted"><day>07</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Health Science Reports</italic> published by Wiley Periodicals LLC.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:HSR2-8-e70502.pdf"/><abstract><title>ABSTRACT</title><sec id="hsr270502-sec-0010"><title>Background</title><p>Obstructive sleep apnea (OSA) is a highly prevalent, yet under&#x02010;diagnosed sleep disorder and has a strong association with type 2 diabetes and diabetic retinopathy (DR). Vascular abnormalities, nocturnal glucose dysregulation, impaired blood flow, and hypoxia during OSA induce oxidative stress and promote the inflammatory pathways which increase the VEGF factor levels, leading to the progression of DR.</p></sec><sec id="hsr270502-sec-0020"><title>Aims</title><p>To date, continuous positive airway pressure (CPAP) is the most effective, gold&#x02010;standard treatment for patients with moderate to severe OSA. However, the implications of CPAP for the treatment of DR due to OSA is still a topic of ongoing debate.</p></sec><sec id="hsr270502-sec-0030"><title>Conclusion</title><p>Evidence suggests that the administration of CPAP therapy led to a reduction in retinal exudates and optical coherence tomography indices for retinal edema and also exhibited improvement in glycemic control, sleepiness, and overall health&#x02010;related quality of life. Nevertheless, there are limited studies present that have evaluated the impact of CPAP therapy on DR in patients with OSA and well&#x02010;designed studies are needed to confirm CPAP's therapeutic effect on DR despite these findings. Moreover, concerns regarding its long&#x02010;term safety, adherence challenges, and inconsistent study designs limit definitive conclusions about CPAP's efficacy in managing DR. This indicates the need for future studies to advocate for enhanced CPAP adherence strategies, refined diagnostic criteria for OSA, and large&#x02010;scale clinical trials to explore CPAP's therapeutic role in DR. Addressing these challenges could revolutionize clinical practices, optimize patient outcomes, and establish CPAP as a cornerstone in the integrated management of OSA and DR.</p></sec></abstract><kwd-group><kwd id="hsr270502-kwd-0001">continuous positive airway pressure</kwd><kwd id="hsr270502-kwd-0002">CPAP</kwd><kwd id="hsr270502-kwd-0003">diabetes mellitus</kwd><kwd id="hsr270502-kwd-0004">diabetic retinopathy</kwd><kwd id="hsr270502-kwd-0005">obstructive sleep apnea</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>The authors received no specific funding for this work.</funding-source></award-group></funding-group><counts><fig-count count="0"/><table-count count="0"/><page-count count="4"/><word-count count="3119"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:26.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="hsr270502-sec-0040"><label>1</label><title>Introduction</title><p>Obstructive sleep apnea (OSA) is a chronic sleep disorder characterized by recurrent episodes of cessation in breathing (apnea) and overly shallow breathing (hyper apnea) during sleep due to mechanical resistance in the upper airway [<xref rid="hsr270502-bib-0001" ref-type="bibr">1</xref>]. Approximately 936 million adults are known to suffer from moderate to severe OSA [<xref rid="hsr270502-bib-0002" ref-type="bibr">2</xref>]. As reported by the American Academy of Sleep Medicine, OSA is a highly underdiagnosed and under&#x02010;reported sleep disorder as 80% of the OSA patients remain undiagnosed [<xref rid="hsr270502-bib-0002" ref-type="bibr">2</xref>]. This condition is particularly prevalent among patients with type 2 diabetes mellitus [<xref rid="hsr270502-bib-0003" ref-type="bibr">3</xref>], indicating an association between sleep disorders and metabolic disorders. Thus, patients experiencing insulin resistance or its complications are at increased risk for developing OSA. Diabetic retinopathy (DR) is the most common microvascular complication of diabetes, and it is also one of the leading causes of blindness in the diabetic population [<xref rid="hsr270502-bib-0004" ref-type="bibr">4</xref>]. It is one of the most common retinal vascular diseases that affects every three in four patients experiencing diabetes for 15 years [<xref rid="hsr270502-bib-0005" ref-type="bibr">5</xref>].</p></sec><sec id="hsr270502-sec-0050"><label>2</label><title>Association Between OSA and DR</title><p>Previous studies have reported a close association between OSA and DR [<xref rid="hsr270502-bib-0006" ref-type="bibr">6</xref>, <xref rid="hsr270502-bib-0007" ref-type="bibr">7</xref>]. The sleep deprivation that occurs due to OSA affects different bodily functions including metabolic control. Studies show an association between poor sleep patterns and an increase in levels of HbA1c [<xref rid="hsr270502-bib-0008" ref-type="bibr">8</xref>]. OSA is also associated with eye disorders like non&#x02010;arteritic anterior ischemic optic neuropathy (NAION), floppy eyelid syndrome (FES), keratoconus (KC), central serous retinopathy (CSR), and glaucoma. Therefore, ophthalmologists seeing patients with any of these conditions should consider screening and referring patients for assessment of possible OSA. In diabetic patients, abnormalities arise in microvasculature which causes stenosis of the vessels, eventually leading to ischemia. In diabetic patients, who often experience vascular abnormalities, nocturnal glucose dysregulation, impaired blood flow, and hypoxia, the intervals of systemic hypoxia during OSA will induce oxidative stress and promote the inflammatory pathways which will further increase the VEGF levels leading to the progression of DR [<xref rid="hsr270502-bib-0001" ref-type="bibr">1</xref>]. Intermittent hypoxia triggers the release of pro&#x02010;inflammatory cytokines, including TNF&#x02010;&#x003b1;, IL&#x02010;8, and IL&#x02010;6 [<xref rid="hsr270502-bib-0009" ref-type="bibr">9</xref>]. Intermittent hypoxia leads to have a stronger inflammatory effect, as repeated cycles of oxygen deprivation and reoxygenation contribute to the generation of reactive oxygen species and heightened oxidative stress [<xref rid="hsr270502-bib-0010" ref-type="bibr">10</xref>]. Consequently, the hypoxic episodes associated with OSA may act as an additional driver of inflammation.</p></sec><sec id="hsr270502-sec-0060"><label>3</label><title>The Role of Continuous Positive Airway Pressure (CPAP) Therapy</title><p>To date, CPAP is the most effective, gold&#x02010;standard treatment for patients with moderate to severe OSA [<xref rid="hsr270502-bib-0011" ref-type="bibr">11</xref>]. A CPAP machine is a device that delivers a continuous stream of pressurized air through a mask worn during sleep. This air stream at higher pressure prevents the airway from narrowing or collapsing while a person is asleep. This can reduce hypoxia&#x02010;related complications, which is beneficial for patients with DR. CPAP also helps in lowering blood pressure which plays a key role in managing OSA and DR. Although, CPAP is the preferred treatment for OSA, not all patients with OSA can tolerate CPAP. To address this issue, alternative modes of pressure delivery have been developed to enhance patient comfort and adherence. Auto&#x02010;adjustable positive airway pressure (APAP) devices can be used for the long&#x02010;term management of OSA and may also aid in the initial diagnosis and titration of conventional CPAP therapy [<xref rid="hsr270502-bib-0012" ref-type="bibr">12</xref>].</p><p>Although, the main findings from Herth et al. indicated no significant effect of CPAP therapy on fasting blood glucose (FBG), HOMA&#x02010;IR, or fructosamine levels but revealed a statistically significant improvement in HbA1c and 24&#x02009;h plasma glucose levels. Therefore, effectively treating OSA with CPAP could lead to a clinically meaningful reduction in HbA1c [<xref rid="hsr270502-bib-0013" ref-type="bibr">13</xref>]. Nevertheless, the implications of CPAP for the treatment of DR due to OSA is still a topic of ongoing debate. In this article, we will try to establish an association between OSA and DR along with the effectiveness and safety of CPAP as a treatment for DR.</p></sec><sec id="hsr270502-sec-0070"><label>4</label><title>Current Evidence on the Efficacy of CPAP Therapy for DR in OSA Patients</title><p>A randomized control trial was conducted from 2016 to 2020, comprising a total of 83 patients that underwent CPAP with concomitant OSA and non&#x02010;proliferative DR. After a median follow&#x02010;up of 52 weeks, it was observed that administration of CPAP therapy led to a reduction in retinal exudates, optical coherence tomography indices for retinal edema and also exhibited improvement in glycemic control, sleepiness, and overall health&#x02010;related quality of life. Overall, it was observed that patients with OSA who undergo long&#x02010;term CPAP treatment have a slower progression of retinal disease. However, there was a higher incidence of retinal microhemorrhages reported with long&#x02010;term treatment with CPAP, indicating the need for future trials to validate the safety profile of CPAP for long&#x02010;term treatment [<xref rid="hsr270502-bib-0014" ref-type="bibr">14</xref>].</p><p>Mason et al. reported that individuals with DR and co&#x02010;existing OSA who are compliant with CPAP therapy with &#x02265;&#x02009;2.5&#x02009;h per night for 6 consecutive months show improvement in visual acuity [<xref rid="hsr270502-bib-0015" ref-type="bibr">15</xref>]. Furthermore, as reported in a retrospective study, high CPAP adherence decreases the progression to advanced DR and maculopathy [<xref rid="hsr270502-bib-0016" ref-type="bibr">16</xref>].</p><p>However, findings from a meta&#x02010;analysis by Zhu et al. [<xref rid="hsr270502-bib-0017" ref-type="bibr">17</xref>] suggested that OSA was significantly associated with an increased risk of DR. Sub&#x02010;group analysis on the type of diabetes mellitus was also performed, and it showed that OSA was linked to the risk of developing DR among both groups of patients with Type 1 and Type 2 diabetes mellitus. Furthermore, studies have reported that around 40%&#x02212;80% of patients with type 2 diabetes mellitus have OSA. The rise in insulin resistance in patients with OSA increases the risk of ocular complications [<xref rid="hsr270502-bib-0018" ref-type="bibr">18</xref>].</p><p>Nevertheless, there are limited studies present that have evaluated the impact of CPAP therapy on DR in patients with OSA and well&#x02010;designed studies are needed to confirm CPAP's therapeutic effect on DR despite these findings.</p></sec><sec id="hsr270502-sec-0080"><label>5</label><title>Current Limitations in Understanding CPAP's Role in DR</title><p>There is a need for better phenotyping of OSA patients. The current diagnostic criteria focus predominantly on anatomical factors, with minimal consideration for other pathophysiological traits, including arousal threshold, loop gain, and muscle tone. Additionally, the existing severity thresholds for OSA, more commonly known as the apnea&#x02010;hypopnea index (AHI), may not fully reflect the clinical impact of OSA. Therefore, revising severity thresholds can lead to more accurate assessment and management decisions. Moreover, patients affected with OSA may exhibit different symptoms and show varied treatment responses. Therefore, qualitative phenotyping incorporating anatomical and non&#x02010;anatomical traits is crucial to understanding distinct OSA subtypes and helps to optimize therapeutic strategies and enhance treatment outcomes [<xref rid="hsr270502-bib-0019" ref-type="bibr">19</xref>].</p><p>Moreover, evidence regarding the importance of positive airway pressure therapy for OSA in improving multiple comorbidities is anecdotal. The long&#x02010;term impact of OSA on DR progression requires further investigation. Addressing this gap is essential for improving clinical management and patient outcomes. Moreover, there is a lack of robust clinical trials that have evaluated the efficacy of CPAP in DR. There is a general estimation of 4&#x02009;h of CPAP usage per night but the evidence supporting this duration is limited [<xref rid="hsr270502-bib-0020" ref-type="bibr">20</xref>]. Additionally, few studies reported adverse effects of CPAP such as increased IOP and superficial keratitis that still have not been thoroughly discussed.</p><p>Moreover, there was a lack of adherence to CPAP therapy in most of the studies [<xref rid="hsr270502-bib-0021" ref-type="bibr">21</xref>]. The reasons for decreased adherence include lack of understanding of CPAP machine usage, claustrophobia, and CPAP mask fitting issues, hence the outcome of these studies could not reflect the actual benefits of CPAP in treating DR. Due to discomfort, pressure intolerance, and mask&#x02010;related issues, the number of hours a patient consistently uses CPAP varies [<xref rid="hsr270502-bib-0022" ref-type="bibr">22</xref>]. Influence is implicated on adherence and overall therapeutic outcomes due to differences between nasal and full&#x02010;face masks [<xref rid="hsr270502-bib-0023" ref-type="bibr">23</xref>]. Furthermore, the pressure settings required to maintain airway patency are not uniform across individuals, making standardization difficult [<xref rid="hsr270502-bib-0024" ref-type="bibr">24</xref>].</p><p>Even though CPAP is effective in lowering AHI, improvement differs among patients, potentially influencing its downstream effects on metabolic and vascular parameters [<xref rid="hsr270502-bib-0025" ref-type="bibr">25</xref>, <xref rid="hsr270502-bib-0026" ref-type="bibr">26</xref>]. Given this variability, future studies should stratify results based on CPAP adherence, pressure settings, and AHI reduction to better understand its role in DR.</p></sec><sec id="hsr270502-sec-0090"><label>6</label><title>Future Directions</title><p>There is limited evidence on the therapeutic potential of CPAP in preventing or delaying the progression of DR. Thus, it remains an area of interest and active research. Therefore, further clinical trials and studies should be conducted on a large sample size, with better compliance and frequent and long&#x02010;term follow&#x02010;ups to validate the efficacy of CPAP in patients with OSA and DR. Adherence with CPAP has been a consistent issue in almost all studies, without which, the results of the trials could not predict the actual effectiveness of CPAP. Therefore, future studies should ensure that participants enrolled in the trial receive adequate training on the usage of CPAP machines, mask fitting, and strategies to decrease discomfort associated with CPAP usage such as nasal congestion, aerophagia, and dry eyes. Furthermore, only those participants should be included in the intervention phase whose adherence and compliance were deemed optimal during the run in period, thereby yielding more accurate study outcomes.</p><p>A detailed study of the optimal hours of CPAP usage should also be conducted. In a recent review, Hanna and Kim explained 6&#x02009;h of CPAP usage is optimal for better improvement opposing the previous 4&#x02009;h criteria for compliance and they also suggested the percentage of total sleep/individualized optimal hours is the best predictor of compliance for an individual. However, these findings need to be thoroughly followed.</p><p>OSA is an under&#x02010;diagnosed condition due to patients ignoring symptoms until they become severe, thereby decreasing the reporting to the physician and decreasing screening since not all patients exhibit similar symptoms, and the severity of the symptoms also varies among patients. Similarly, DR is a silent disease until it progresses to blindness. For better treatment outcomes and prevention of OSA&#x02010;related complications, it is crucial to screen all diabetic patients visiting the clinics for any of the symptoms related to OSA and refer them for DR evaluation for early diagnosis and initiation of treatment before the complications begin.</p></sec><sec sec-type="conclusions" id="hsr270502-sec-0100"><label>7</label><title>Conclusion</title><p>In conclusion, the intricate relationship between OSA and DR highlights a pressing need for further exploration of the therapeutic potential of CPAP for the management of DR. However, the current evidence reveals significant gaps in understanding, and definitive conclusions remain elusive. This calls for the need for comprehensive, well&#x02010;designed clinical trials with larger sample sizes, improved adherence of the participants, and longer and more structured follow&#x02010;ups to validate the effectiveness of CPAP therapy for OSA&#x02010;linked DR. Addressing these gaps could transform the clinical practice and pave the way for more effective treatment strategies, thereby enhancing the patient outcomes.</p></sec><sec id="hsr270502-sec-0110"><title>Author Contributions</title><p>
<bold>Sadia Ayoub:</bold> conceptualization, writing&#x02013;original draft, writing&#x02013;review and editing. <bold>Hira Tanweer:</bold> conceptualization, writing&#x02013;original draft. <bold>Hafiza Aiman Javaid:</bold> writing&#x02013;original draft. <bold>Minahil Nasreen Khan:</bold> writing&#x02013;original draft. <bold>Shahzaib Ahmed:</bold> writing&#x02013;review and editing. <bold>Mohammed Mahmmoud Fadelallah Eljack:</bold> supervision, writing&#x02013;review and editing. All authors have read and approved the final version of the manuscript.</p></sec><sec id="hsr270502-sec-0130"><title>Ethics Statement</title><p>The authors have nothing to report.</p></sec><sec sec-type="COI-statement" id="hsr270502-sec-0140"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="hsr270502-sec-0170"><title>Transparency Statement</title><p>The lead author, Mohammed Mahmmoud Fadelallah Eljack, affirms that this manuscript is an honest, accurate, and transparent account of the study being reported, that no important aspects of the study have been omitted, and that any discrepancies from the study as planned (and if relevant, registered) have been explained.</p></sec></body><back><ack id="hsr270502-sec-0120"><title>Acknowledgments</title><p>The authors have nothing to report.</p></ack><sec sec-type="data-availability" id="hsr270502-sec-0160"><title>Data Availability Statement</title><p>Data sharing is not applicable to this article as no data sets were generated or analyzed during the current study.</p></sec><ref-list content-type="cited-references" id="hsr270502-bibl-0001"><title>References</title><ref id="hsr270502-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="hsr270502-cit-0001">
<string-name>
<given-names>S.</given-names>
<surname>Reutrakul</surname>
</string-name> and <string-name>
<given-names>B.</given-names>
<surname>Mokhlesi</surname>
</string-name>, &#x0201c;<article-title>Obstructive Sleep Apnea and Diabetes</article-title>,&#x0201d; <source>Chest</source>
<volume>152</volume> (<year>2017</year>): <fpage>1070</fpage>&#x02013;<lpage>1086</lpage>, <pub-id pub-id-type="doi">10.1016/j.chest.2017.05.009</pub-id>.<pub-id pub-id-type="pmid">28527878</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0002"><label>2</label><mixed-citation publication-type="miscellaneous" id="hsr270502-cit-0002">
<string-name>
<given-names>V.</given-names>
<surname>Ling</surname>
</string-name>, &#x0201c;Sleep Apnea Statistics and Facts You Should Know, National Council of Aging,&#x0201d; <year>2024</year>, <ext-link xlink:href="https://www.ncoa.org/adviser/sleep/sleep-apnea-statistics/" ext-link-type="uri">https://www.ncoa.org/adviser/sleep/sleep-apnea-statistics/</ext-link>.</mixed-citation></ref><ref id="hsr270502-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="hsr270502-cit-0003">
<string-name>
<given-names>P.</given-names>
<surname>Saxena</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Singh</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Singh</surname>
</string-name>, &#x0201c;<article-title>Prevalence and Impact of Obstructive Sleep Apnea in Type 2 Diabetes Mellitus: A Descriptive Cross&#x02010;Sectional Study</article-title>,&#x0201d; <source>Medical Journal, Armed Forces India</source>
<volume>80</volume> (<year>2024</year>): <fpage>50</fpage>, <pub-id pub-id-type="doi">10.1016/j.mjafi.2022.07.008</pub-id>.</mixed-citation></ref><ref id="hsr270502-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="hsr270502-cit-0004">
<string-name>
<given-names>J.</given-names>
<surname>Grauslund</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Stokholm</surname>
</string-name>, <string-name>
<given-names>A. S.</given-names>
<surname>Thykj&#x000e6;r</surname>
</string-name>, et al., &#x0201c;<article-title>Inverse Cross&#x02010;Sectional and Longitudinal Relationships Between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes</article-title>,&#x0201d; <source>Ophthalmology Science</source>
<volume>1</volume> (<year>2021</year>): <elocation-id>100011</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.xops.2021.100011</pub-id>.<pub-id pub-id-type="pmid">36246011</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="hsr270502-cit-0005">
<string-name>
<given-names>T. H.</given-names>
<surname>Fung</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Patel</surname>
</string-name>, <string-name>
<given-names>E. G.</given-names>
<surname>Wilmot</surname>
</string-name>, and <string-name>
<given-names>W. M.</given-names>
<surname>Amoaku</surname>
</string-name>, &#x0201c;<article-title>Diabetic Retinopathy for the Non&#x02010;Ophthalmologist</article-title>,&#x0201d; <source>Clinical Medicine (London, England)</source>
<volume>22</volume> (<year>2022</year>): <fpage>112</fpage>&#x02013;<lpage>116</lpage>, <pub-id pub-id-type="doi">10.7861/clinmed.2021-0792</pub-id>.<pub-id pub-id-type="pmid">35304370</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="hsr270502-cit-0006">
<string-name>
<given-names>S.</given-names>
<surname>Ba&#x02010;Ali</surname>
</string-name>, <string-name>
<given-names>P. J.</given-names>
<surname>Jennum</surname>
</string-name>, <string-name>
<given-names>A. E.</given-names>
<surname>Br&#x000f8;ndsted</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Heegaard</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Lund&#x02010;Andersen</surname>
</string-name>, &#x0201c;<article-title>The Role of Obstructive Sleep Apnea in Vision&#x02010;Threatening Diabetic Retinopathy&#x02014;A National Register&#x02010;Based Study</article-title>,&#x0201d; <source>Journal of Personalized Medicine</source>
<volume>13</volume> (<year>2023</year>): <elocation-id>1529</elocation-id>, <pub-id pub-id-type="doi">10.3390/jpm13111529</pub-id>.<pub-id pub-id-type="pmid">38003844</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="hsr270502-cit-0007">
<string-name>
<given-names>M.</given-names>
<surname>Simonson</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Zhu</surname>
</string-name>, et al., &#x0201c;<article-title>Multidimensional Sleep Health and Diabetic Retinopathy: Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Sleep Medicine Reviews</source>
<volume>74</volume> (<year>2024</year>): <elocation-id>101891</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.smrv.2023.101891</pub-id>.<pub-id pub-id-type="pmid">38118339</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="hsr270502-cit-0008">
<string-name>
<given-names>S. W. H.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>K. Y.</given-names>
<surname>Ng</surname>
</string-name>, and <string-name>
<given-names>W. K.</given-names>
<surname>Chin</surname>
</string-name>, &#x0201c;<article-title>The Impact of Sleep Amount and Sleep Quality on Glycemic Control in Type 2 Diabetes: A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Sleep Medicine Reviews</source>
<volume>31</volume> (<year>2017</year>): <fpage>91</fpage>&#x02013;<lpage>101</lpage>, <pub-id pub-id-type="doi">10.1016/j.smrv.2016.02.001</pub-id>.<pub-id pub-id-type="pmid">26944909</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="hsr270502-cit-0009">
<string-name>
<given-names>S.</given-names>
<surname>Ryan</surname>
</string-name>, <string-name>
<given-names>C. T.</given-names>
<surname>Taylor</surname>
</string-name>, and <string-name>
<given-names>W. T.</given-names>
<surname>McNicholas</surname>
</string-name>, &#x0201c;<article-title>Selective Activation of Inflammatory Pathways by Intermittent Hypoxia in Obstructive Sleep Apnea Syndrome</article-title>,&#x0201d; <source>Circulation</source>
<volume>112</volume>, no. <issue>17</issue> (October <year>2005</year>): <fpage>2660</fpage>&#x02013;<lpage>2667</lpage>, <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.556746</pub-id>.<pub-id pub-id-type="pmid">16246965</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="hsr270502-cit-0010">
<string-name>
<given-names>L.</given-names>
<surname>Lavie</surname>
</string-name>, &#x0201c;<article-title>Oxidative Stress: A Unifying Paradigm in Obstructive Sleep Apnea and Comorbidities</article-title>,&#x0201d; <source>Progress in Cardiovascular Diseases</source>
<volume>51</volume>, no. <issue>4</issue> (January/February <year>2009</year>): <fpage>303</fpage>&#x02013;<lpage>312</lpage>, <pub-id pub-id-type="doi">10.1016/j.pcad.2008.08.003</pub-id>.<pub-id pub-id-type="pmid">19110132</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="hsr270502-cit-0011">
<string-name>
<given-names>S. R.</given-names>
<surname>Patel</surname>
</string-name>, &#x0201c;<article-title>Obstructive Sleep Apnea</article-title>,&#x0201d; <source>Annals of Internal Medicine</source>
<volume>171</volume> (<year>2019</year>): <fpage>ITC81</fpage>&#x02013;<lpage>ITC96</lpage>, <pub-id pub-id-type="doi">10.7326/aitc201912030</pub-id>.<pub-id pub-id-type="pmid">31791057</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="hsr270502-cit-0012">
<string-name>
<given-names>J. F.</given-names>
<surname>Garvey</surname>
</string-name> and <string-name>
<given-names>W. T.</given-names>
<surname>McNicholas</surname>
</string-name>, &#x0201c;<article-title>Continuous Positive Airway Pressure Therapy: New Generations</article-title>,&#x0201d; <source>Indian Journal of Medical Research</source>
<volume>131</volume> (<year>2010</year>): <fpage>259</fpage>&#x02013;<lpage>266</lpage>.<pub-id pub-id-type="pmid">20308751</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="hsr270502-cit-0013">
<string-name>
<given-names>J.</given-names>
<surname>Herth</surname>
</string-name>, <string-name>
<given-names>N. A.</given-names>
<surname>Sievi</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Schmidt</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Kohler</surname>
</string-name>, &#x0201c;<article-title>Effects of Continuous Positive Airway Pressure Therapy on Glucose Metabolism in Patients With Obstructive Sleep Apnoea and Type 2 Diabetes: A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>European Respiratory Review</source>
<volume>32</volume> (<year>2023</year>): <elocation-id>230083</elocation-id>, <pub-id pub-id-type="doi">10.1183/16000617.0083-2023</pub-id>.<pub-id pub-id-type="pmid">37673425</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="hsr270502-cit-0014">
<string-name>
<given-names>A.</given-names>
<surname>Garc&#x000ed;a&#x02010;S&#x000e1;nchez</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Villala&#x000ed;n&#x02010;Rodes</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Jaureguizar</surname>
</string-name>, et al., &#x0201c;<article-title>Continuous Positive Airway Pressure Effect on Progression of Retinal Disease in Patients With Sleep Apnea and Nonproliferative Diabetic Retinopathy: A Randomized Clinical Trial</article-title>,&#x0201d; <source>Annals of the American Thoracic Society</source>
<volume>21</volume> (<year>2024</year>): <fpage>102</fpage>&#x02013;<lpage>113</lpage>, <pub-id pub-id-type="doi">10.1513/AnnalsATS.202304-296OC</pub-id>.<pub-id pub-id-type="pmid">37793101</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="hsr270502-cit-0015">
<string-name>
<given-names>R. H.</given-names>
<surname>Mason</surname>
</string-name>, <string-name>
<given-names>C. A.</given-names>
<surname>Kiire</surname>
</string-name>, <string-name>
<given-names>D. C.</given-names>
<surname>Groves</surname>
</string-name>, et al., &#x0201c;<article-title>Visual Improvement Following Continuous Positive Airway Pressure Therapy in Diabetic Subjects With Clinically Significant Macular Oedema and Obstructive Sleep Apnoea: Proof of Principle Study</article-title>,&#x0201d; <source>Respiration</source>
<volume>84</volume> (<year>2012</year>): <fpage>275</fpage>&#x02013;<lpage>282</lpage>, <pub-id pub-id-type="doi">10.1159/000334090</pub-id>.<pub-id pub-id-type="pmid">22189259</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="hsr270502-cit-0016">
<string-name>
<given-names>Q. A.</given-names>
<surname>Altaf</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Dodson</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Ali</surname>
</string-name>, et al., &#x0201c;<article-title>Obstructive Sleep Apnea and Retinopathy in Patients With Type 2 Diabetes: A Longitudinal Study</article-title>,&#x0201d; <source>American Journal of Respiratory and Critical Care Medicine</source>
<volume>196</volume> (<year>2017</year>): <fpage>892</fpage>&#x02013;<lpage>900</lpage>, <pub-id pub-id-type="doi">10.1164/rccm.201701-0175OC</pub-id>.<pub-id pub-id-type="pmid">28594570</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="hsr270502-cit-0017">
<string-name>
<given-names>Z.</given-names>
<surname>Zhu</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, et al., &#x0201c;<article-title>Relationship of Obstructive Sleep Apnoea With Diabetic Retinopathy: A Meta&#x02010;Analysis</article-title>,&#x0201d; <source>BioMed Research International</source>
<volume>2017</volume> (<year>2017</year>): <fpage>1</fpage>&#x02013;<lpage>5</lpage>, <pub-id pub-id-type="doi">10.1155/2017/4737064</pub-id>.</mixed-citation></ref><ref id="hsr270502-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="hsr270502-cit-0018">
<string-name>
<given-names>M.</given-names>
<surname>Michalek&#x02010;Zrabkowska</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Macek</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Martynowicz</surname>
</string-name>, et al., &#x0201c;<article-title>Obstructive Sleep Apnea as a Risk Factor of Insulin Resistance in Nondiabetic Adults</article-title>,&#x0201d; <source>Life</source>
<volume>11</volume> (<year>2021</year>): <elocation-id>50</elocation-id>, <pub-id pub-id-type="doi">10.3390/life11010050</pub-id>.<pub-id pub-id-type="pmid">33451031</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="hsr270502-cit-0019">
<string-name>
<given-names>M.</given-names>
<surname>Bosi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>De Vito</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Eckert</surname>
</string-name>, et al., &#x0201c;<article-title>Qualitative Phenotyping of Obstructive Sleep Apnea and Its Clinical Usefulness for the Sleep Specialist</article-title>,&#x0201d; <source>International Journal of Environmental Research and Public Health</source>
<volume>17</volume> (<year>2020</year>): <elocation-id>2058</elocation-id>, <pub-id pub-id-type="doi">10.3390/ijerph17062058</pub-id>.<pub-id pub-id-type="pmid">32244892</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="hsr270502-cit-0020">
<string-name>
<given-names>S. D.</given-names>
<surname>West</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Prudon</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Hughes</surname>
</string-name>, et al., &#x0201c;<article-title>Continuous Positive Airway Pressure Effect on Visual Acuity in Patients With Type 2 Diabetes and Obstructive Sleep Apnoea: A Multicentre Randomised Controlled Trial</article-title>,&#x0201d; <source>European Respiratory Journal</source>
<volume>52</volume> (<year>2018</year>): <elocation-id>1801177</elocation-id>, <pub-id pub-id-type="doi">10.1183/13993003.01177-2018</pub-id>.<pub-id pub-id-type="pmid">30166323</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="hsr270502-cit-0021">
<string-name>
<given-names>M.</given-names>
<surname>Qiao</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Xie</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Wolff</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Kwon</surname>
</string-name>, &#x0201c;<article-title>Long Term Adherence to Continuous Positive Airway Pressure in Mild Obstructive Sleep Apnea</article-title>,&#x0201d; <source>BMC Pulmonary Medicine</source>
<volume>23</volume> (<year>2023</year>): <fpage>320</fpage>, <pub-id pub-id-type="doi">10.1186/s12890-023-02612-3</pub-id>.<pub-id pub-id-type="pmid">37658304</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="hsr270502-cit-0022">
<string-name>
<given-names>S.</given-names>
<surname>Aalaei</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Rezaeitalab</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Tabesh</surname>
</string-name>, et al., &#x0201c;<article-title>Factors Affecting Patients' Adherence to Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea Disorder: A Multi&#x02010;Method Approach</article-title>,&#x0201d; <source>Iranian Journal of Medical Sciences</source>
<volume>45</volume>, no. <issue>3</issue> (May <year>2020</year>): <fpage>170</fpage>&#x02013;<lpage>178</lpage>, <pub-id pub-id-type="doi">10.30476/ijms.2019.45785</pub-id>.<pub-id pub-id-type="pmid">32546883</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="hsr270502-cit-0023">
<string-name>
<given-names>P. R.</given-names>
<surname>Genta</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kaminska</surname>
</string-name>, <string-name>
<given-names>B. A.</given-names>
<surname>Edwards</surname>
</string-name>, et al., &#x0201c;<article-title>The Importance of Mask Selection on Continuous Positive Airway Pressure Outcomes for Obstructive Sleep Apnea. An Official American Thoracic Society Workshop Report</article-title>,&#x0201d; <source>Annals of the American Thoracic Society</source>
<volume>17</volume>, no. <issue>10</issue> (October <year>2020</year>): <fpage>1177</fpage>&#x02013;<lpage>1185</lpage>, <pub-id pub-id-type="doi">10.1513/AnnalsATS.202007-864ST</pub-id>.<pub-id pub-id-type="pmid">33000960</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0024"><label>24</label><mixed-citation publication-type="book" id="hsr270502-cit-0024">
<string-name>
<given-names>V. L.</given-names>
<surname>Pinto</surname>
</string-name> and <string-name>
<given-names>S.</given-names>
<surname>Sharma</surname>
</string-name>, &#x0201c;<part-title>Continuous Positive Airway Pressure</part-title>,&#x0201d; in <source>StatPearls [Internet]</source> (<publisher-name>StatPearls Publishing</publisher-name>, <year>2025</year>), <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK482178/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK482178/</ext-link>.</mixed-citation></ref><ref id="hsr270502-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="hsr270502-cit-0025">
<string-name>
<given-names>J.</given-names>
<surname>Oyama</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Yamamoto</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Maeda</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Ito</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Node</surname>
</string-name>, and <string-name>
<given-names>N.</given-names>
<surname>Makino</surname>
</string-name>, &#x0201c;<article-title>Continuous Positive Airway Pressure Therapy Improves Vascular Dysfunction and Decreases Oxidative Stress in Patients With the Metabolic Syndrome and Obstructive Sleep Apnea Syndrome</article-title>,&#x0201d; <source>Clinical Cardiology</source>
<volume>35</volume>, no. <issue>4</issue> (April <year>2012</year>): <fpage>231</fpage>&#x02013;<lpage>236</lpage>, <pub-id pub-id-type="doi">10.1002/clc.21010</pub-id>.<pub-id pub-id-type="pmid">22278815</pub-id>
</mixed-citation></ref><ref id="hsr270502-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="hsr270502-cit-0026">
<string-name>
<given-names>S.</given-names>
<surname>Parthasarathy</surname>
</string-name>, <string-name>
<given-names>V. S.</given-names>
<surname>Vasanthkumar</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Balaji</surname>
</string-name>, &#x0201c;<article-title>Retinal Diabetopathy? Sleep Disorders, Retinal Changes, and Insulin Resistance: A Synthesized Systematic Review</article-title>,&#x0201d; <source>Asian Journal of Pharmaceutical Research and Health Care</source>
<volume>16</volume>, no. <issue>3</issue> (July/September <year>2024</year>): <fpage>233</fpage>&#x02013;<lpage>238</lpage>, <pub-id pub-id-type="doi">10.4103/ajprhc.ajprhc_62_24</pub-id>.</mixed-citation></ref></ref-list></back></article>